<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
BIIB
Biogen
$
()


  • Eisai, Biogen say FDA accepted sBLA for monthly LEQEMBI IV maintenance dosing

    6/9/2024 - 19:42pm
  • Biogen, Delta Flight Products collaborate for accessible air travel

    6/3/2024 - 07:34am
  • Biogen granted marketing authorization for Qalsody by EC

    5/30/2024 - 16:53pm
  • Biogen reports Leqembi approved for treatment of Alzheimer's in South Korea

    5/28/2024 - 07:19am
  • Biotech Alert: Searches spiking for these stocks today

    5/24/2024 - 11:18am
  • Biogen acquiring HI-Bio in increased immunology focus, says William Blair

    5/22/2024 - 12:30pm
  • Biogen acquisition has positive read for IGM Biosciences, says RBC Capital

    5/22/2024 - 11:46am
  • Biogen deal for HI-Bio 'makes sense,' says Stifel

    5/22/2024 - 09:45am
  • Biogen to acquire Human Immunology Biosciences for $1.15B upfront

    5/22/2024 - 07:33am
  • What You Missed On Wall Street On Thursday

    5/16/2024 - 16:16pm
  • Biogen says won't exercise option to license and lead development of BIIB121

    5/16/2024 - 12:37pm
  • What You Missed On Wall Street This Morning

    5/16/2024 - 11:57am
  • Biogen, Ionis terminate development of BIIB105 based on data from ALSpire study

    5/16/2024 - 07:33am
  • Eisai/Biogen initiate FDA BLA for LEQEMBI

    5/14/2024 - 19:53pm
  • Biogen price target raised by $3 at HSBC, here's why

    5/3/2024 - 08:08am
dynamic_feed Breaking News